Feasibility of using guidelines to choose treatment for prostate cancer

Canadian Journal of Urology

Volumn 17, Issue 1, 2010, Pages 4975-4984

  Mohan, Ravinder ^a   Beydoun, Hind ^a   Davis, John ^b   Lance, Raymond ^a   Schellhammer, Paul ^a  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Guidelines; Localized prostate cancer; Treatment

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; BLOOD; COMORBIDITY; HUMAN; INFORMATION PROCESSING; LIFE EXPECTANCY; MALE; MIDDLE AGED; MORTALITY; PATHOLOGY; PATIENT PREFERENCE; PRACTICE GUIDELINE; PROSTATE TUMOR; RISK; SURVIVAL; TUMOR RECURRENCE; WATCHFUL WAITING;

COMORBIDITY; DATA COLLECTION; HUMANS; LIFE EXPECTANCY; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PATIENT PREFERENCE; PRACTICE GUIDELINES AS TOPIC; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RISK; SURVIVAL ANALYSIS; WATCHFUL WAITING;

EID: 79952113821     PISSN: 11959479     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Miller D, Gruber S, Hollenbeck B, Montie J, Wei J. Incidence of initial local therapy among men with lower-risk prostate cancer in the United States. J Natl Cancer Inst 2006;98(16):1134-1141.
2. Harlan SR, Cooperberg MR, Elkin EP, Lubeck DP, Meng MV, Mehta SS, Carroll PR. Time trends and characteristics of men choosing watchful waiting for initial treatment of localized prostate cancer:results from CaPSURE. J Urol 2003;170(5):1804-1807.
3. Albertsen P, Hanley J, Fine J. 20-year outcomes following conservative management of clinically localized prostate cancer. JAMA 2005;293(17):2095-2101.
4. Draisma G, Boer R, Otto S, van der Cruijsen I, Damhuis R, Schröder F, de Koning H. Lead times and overdetection due to prostate-specific antigen screening:estimates from the European Randomized Study of Screening for Prostate Cancer. J Natl Cancer Inst 2003;95(12):868-878.
5. Klotz L. Active surveillance for prostate cancer:for whom? J Clin Oncol 2005;23(32):8165-8169.
6. van den Bergh R, Roemeling S, Roobol M, Aus G, Hugosson J, Rannikko A, Tammela TL, Bangma CH, Schroder FH. Outcomes of men with screen-detected prostate cancer eligible for active surveillance who were managed expectantly. Eur Urol 2009;55(1):1-8.
7. Miller D, Sanda M, Dunn R, Montie J, Pimentel H, Sandler H, McLaughlin W, Wei J. Long-term outcomes among localized prostate cancer survivors:health-related quality-of-life changes after radical prostatectomy, external radiation, and brachytherapy. J Clin Oncol 2005;23(12):2772-2780.
8. Ruchlin H, Pellissier J. An economic overview of prostate carcinoma. Cancer 2001;92(11):2796-2810.
9. Shavers V, Brown M. Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst 2002;94(5):334-357.
10. Alibhai S, Naglie G, Nam R, Trachtenberg J, Krahn M. Do older men benefit from curative therapy of localized prostate cancer? J Clin Oncol 2003;21(17):3318-3327.
11. Fowler FJ, McNaughton Collins M, Albertsen P, Zietman A, Elliott D, Barry M. Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer. JAMA 2000;283(24):3217-3222.
12. Kistler C, Lewis C, Amick H, Bynum D, Walter L, Watson L. Older adults' beliefs about physician-estimated life expectancy:a cross-sectional survey. BMC Fam Pract 2006;7:9.
13. Wilson J, Clarke M, Ewings P, Graham J, MacDonagh R. The assessment of patient life-expectancy:how accurate are urologists and oncologists? BJU Int 2005;95(6):794-798.
14. Walz J, Gallina A, Saad F, Montorsi F, Perrotte P, Shariat S, Jeldres C, Graefen M, Benard F, McCormack M, Valiquette L, Karakiewicz PI. A nomogram predicting 10-year life expectancy in candidates for radical prostatectomy or radiotherapy for prostate cancer. J Clin Oncol 2007;25(24):3576-3581.
15. Post P, Hansen B, Kil P, Janssen-Heijnen M, Coebergh J. The independent prognostic value of comorbidity among men aged < 75 years with localized prostate cancer:a population-based study. BJU Int 2001;87(9):821-826.
16. Walter L, Covinsky K. Cancer screening in elderly patients:a framework for individualized decision making. JAMA 2001;285(21):2750-2756.
17. National Comprehensive Cancer Network. Prostate Cancer. Practice Guidelines in Oncology v.2. Available from URL:http:// www.nccn.org/professionals/physician_gls/PDF/prostate.pdf. Accessed July 17th, 2009.
18. Hoffman R, Stone S, Espey D, Potosky A. Differences between men with screening-detected versus clinically diagnosed prostate cancers in the USA. BMC Cancer 2005;5:27.
19. Mohan R, Beydoun H, Barnes-Ely M, Lee L, Davis J, Lance R, Schellhammer P. Patients' survival expectations before localized prostate cancer treatment by treatment status. J Am Board Fam Med 2009;22(3):247-256.
20. Ware JE, Kosinski M. SF-36 Physical and Mental Health Summary Scales:A Manual for Users of Version 1. 2 ed. Lincoln, RI:QualiMetric Incorporated, 2005.
21. Litwin M, Hays R, Fink A, Ganz P, Leake B, Brook R. The UCLA Prostate Cancer Index:development, reliability, and validity of a health-related quality of life measure. Med Care 1998;36(7):1002-1012.
22. Hlatky M, Boineau R, Higginbotham M, Lee K, Mark D, Califf R, Cobb F, Pryor D. A brief self-administered questionnaire to determine functional capacity (the Duke Activity Status Index). Am J Cardiol 1989;64(10):651-654.
23. Zigmond A, Snaith R. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67(6):361-70.
24. Mehta S, Lubeck D, Pasta D, Litwin M. Fear of cancer recurrence in patients undergoing definitive treatment for prostate cancer:results from CaPSURE. J Urol 2003;170(5):1931-1933.
25. Sherbourne C, Stewart A. The MOS social support survey. Soc Sci Med 1991;32(6):705-714.
26. Bass Pr, Wilson J, Griffith C. A shortened instrument for literacy screening. J Gen Intern Med 2003;18(12):1036-1038.
27. Cooperberg M, Lubeck D, Meng M, Mehta S, Carroll P. The changing face of low-risk prostate cancer:trends in clinical presentation and primary management. J Clin Oncol 2004;22(11):2141-2149.
28. Parker C, Muston D, Melia J, Moss S, Dearnaley D. A model of the natural history of screen-detected prostate cancer, and the effect of radical treatment on overall survival. Br J Cancer 2006;94(10):1361-1368.
29. Cooperberg M, Broering J, Kantoff P, Carroll P. Contemporary trends in low risk prostate cancer:risk assessment and treatment. J Urol 2007;178(3 Pt 2):S14-S19.
30. Dahm P, Kunz R, Schünemann H. Evidence-based clinical practice guidelines for prostate cancer:the need for a unified approach. Curr Opin Urol 2007;17(3):200-207.
31. Walter L, Lindquist K, Nugent S, Schult T, Lee S, Casadei M, Partin MR. Impact of age and comorbidity on colorectal cancer screening among older veterans. Ann Intern Med 2009;150(7):465-473.
32. Froehner M, Koch R, Litz R, Oehlschlaeger S, Wirth MP. Which conditions contributing to the Charlson score predict survival after radical prostatectomy? J Urol 2004;171(2 Pt 1):697-699.
33. Froehner M, Koch R, Litz R, Oehlschlaeger S, Twelker L, Hakenberg O, Wirth M. Detailed analysis of Charlson comorbidity score as predictor of mortality after radical prostatectomy. Urology 2008;72(6):1252-1257.
34. National Cancer Institute. State Cancer Profiles. Historical Trends (1981-2005) Mortality, United States. Prostate, Male. All Ages. Deaths per 100,000 resident population. Available from URL:http://statecancerprofiles.cancer.gov/cgi-bin/quickprofiles/ profile.pl?00&066#jpMort. Accessed July 17, 2009.
35. Singh R, O'Brien T. Comorbidity assessment in localized prostate cancer:a review of currently available techniques. Eur Urol 2004;46(1):28-41.
36. Welch H, Albertsen P, Nease R, Bubolz T, Wasson J. Estimating treatment benefits for the elderly:the effect of competing risks. Ann Intern Med 1996;124(6):577-584.
37. Lee S, Lindquist K, Segal M, Covinsky K. Development and validation of a prognostic index for 4-year mortality in older adults. JAMA 2006;295(7):801-808.
38. de Craen A, Westendorp R. Prognostic index for 4-year mortality in older adults. JAMA 2006;296(6):648.
39. DeSalvo K, Bloser N, Reynolds K, He J, Muntner P. Mortality prediction with a single general self-rated health question. A meta-analysis. J Gen Intern Med 2006;21(3):267-275.